Abstract:OBJECT: Studies have suggested that depression was accompanied by oxidative stress dysregulation, including abnormal total antioxidant capacity (TAC), antioxidants, free radicals, oxidative damage and autoimmune response products. This meta-analysis aims to analyse the clinical data quantitatively by comparing the oxidative stress markers between depressed patients and healthy controls.METHODS: A search was conducted to collect the studies that measured the oxidative stress markers in depressed patients. Studies were searched in Embase, Medline, PsychINFO, Science direct, CBMDisc, CNKI and VIP from 1990 to May 2015. Data were subjected to meta-analysis by using a random effects model for examining the effect sizes of the results. Bias assessments, heterogeneity assessments and sensitivity analyses were also conducted.RESULTS: 115 articles met the inclusion criteria. Lower TAC was noted in acute episodes (AEs) of depressed patients (p<0.05). Antioxidants, including serum paraoxonase, uric acid, albumin, high-density lipoprotein cholesterol and zinc levels were lower than controls (p<0.05); the serum uric acid, albumin and vitamin C levels were increased after antidepressant therapy (p<0.05). Oxidative damage products, including red blood cell (RBC) malondialdehyde (MDA), serum MDA and 8-F2-isoprostanes levels were higher than controls (p<0.05). After antidepressant medication, RBC and serum MDA levels were decreased (p<0.05). Moreover, serum peroxide in free radicals levels were higher than controls (p<0.05). There were no differences between the depressed patients and controls for other oxidative stress markers.CONCLUSION: This meta-analysis supports the facts that the serum TAC, paraoxonase and antioxidant levels are lower, and the serum free radical and oxidative damage product levels are higher than controls in depressed patients. Meanwhile, the antioxidant levels are increased and the oxidative damage product levels are decreased after antidepressant medication. The pathophysiological relationships between oxidative stress and depression, and the potential benefits of antioxidant supplementation deserve further research.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: whether patients with depression are accompanied by oxidative stress disorders, specifically manifested as abnormal changes in total antioxidant capacity (TAC), antioxidants, free radicals, oxidative damage and products of autoimmune responses. By comparing oxidative stress markers between patients with depression and the healthy control group, the author hopes to quantitatively analyze the clinical significance of these markers in depression and explore the impact of antidepressant treatment on these markers. ### Research Background Depression is a common mental illness that affects the quality of life of millions of people around the world. Although its pathological mechanism has not been fully clarified, recent studies have shown that oxidative stress may play an important role in the pathogenesis of depression. Oxidative stress refers to the imbalance between the oxidation and antioxidant systems in the body, leading to damage to cellular macromolecules (such as lipids, proteins and DNA). Abnormal levels of oxidative products have been found in the peripheral blood, red blood cells, monocytes, urine, cerebrospinal fluid and post - mortem brain tissue of patients with depression, suggesting that oxidative stress may be closely related to depression. ### Research Objectives The main objective of this study is to systematically evaluate the differences in oxidative stress markers between patients with depression and the healthy control group through meta - analysis and quantify the magnitude of these differences. Specifically, the author hopes to answer the questions through the following aspects: 1. **Compare the levels of oxidative stress markers between patients with depression and the healthy control group**: - Total antioxidant capacity (TAC) - Non - enzymatic antioxidants (such as vitamin C, E, albumin, uric acid, high - density lipoprotein cholesterol (HDL - C), zinc, etc.) - Enzymatic antioxidants (such as superoxide dismutase (SOD), glutathione peroxidase (GPX), catalase (CAT), glutathione reductase (GR), paraoxonase 1 (PON1), etc.) - Free radicals (such as peroxides, nitrates / nitrites, nitric oxide (NO), etc.) - Oxidative damage products (such as malondialdehyde (MDA), 8 - iso - prostaglandin F2α (8 - iso - PGF2α), protein carbonyl (PC), etc.) 2. **Evaluate the impact of antidepressant treatment on oxidative stress markers**: - Changes in the above - mentioned oxidative stress markers before and after antidepressant treatment. ### Research Methods The author collected relevant literatures published from 1990 to May 2015 by retrieving multiple databases (such as Embase, Medline, PsychINFO, ScienceDirect, CBMDisc, CNKI and VIP). A random - effects model was used for meta - analysis to calculate the effect size of each oxidative stress marker. In addition, bias assessment, heterogeneity assessment and sensitivity analysis were also carried out to ensure the reliability and stability of the results. ### Main Findings 1. **Performance of patients with depression in the acute - onset phase**: - Serum TAC, PON, uric acid, albumin, HDL - C and zinc levels are lower than those in the healthy control group. - Serum peroxide, MDA, 8 - iso - PGF2α and erythrocyte MDA levels are higher than those in the healthy control group. 2. **Changes after antidepressant treatment**: - Serum uric acid, albumin and vitamin C levels increase. - Serum nitrate / nitrite, erythrocyte and serum MDA levels decrease. ### Conclusions This meta - analysis supports the view that patients with depression have oxidative stress disorders, manifested as a decrease in antioxidant capacity and an increase in oxidative damage products. Antidepressant treatment can partially reverse these abnormal changes, suggesting a close relationship between oxidative stress and depression. Future research is needed to further study the pathophysiological relationship between oxidative stress and depression, as well as the potential benefits of antioxidant supplements. ### Formula Summary The formulas involved in this paper include the calculation formula of effect size (ES), using the standardized mean difference (SMD) method, as follows: \[ ES=\frac{\bar{X}_D - \bar{X}_C}{SD} \] where \(\bar{X}_D\) and \(\bar{X}_C\) are the means of the depression patient group and the healthy control group respectively, and \(SD\) is the standard deviation.

A Meta-Analysis of Oxidative Stress Markers in Depression